Michael A. Kass, MD

Professor, Ophthalmology and Visual Sciences

Patients Seen At: (314) 362-3937

Fax: (314) 362-3725

Email: Kass@vision.wustl.edu

Click here for Dr. Kass lab website

Education

  • B.S.: Northwestern University, Chicago, Illinois, 1963
  • Medical School: Northwestern University, Chicago, Illinois, 1966

Training

  • Residency: Washington University, St. Louis, Missouri, 1971
  • Fellowship: Washington University, St. Louis, Missouri, 1972

Licensure and Board Certification

  • Ophthalmology -- Certified

Honors and Awards

  • Listed in Best Doctors in America, 2002-2013 (Best Doctors, Inc.)
  • Listed in America's Top Doctors, 2002-2012 (Castle Connolly Medical Ltd.)

Selected Publications

  1. Gao F, Miller JP, Miglior S, Beiser JA, Torri V, Kass MA, Gordon MO. The effect of changes in intraocular pressure on the risk of primary open-angle glaucoma in patients with ocular hypertension: an application of latent class analysis. BMC Med Res Methodol. 2012 Oct 4;12:151.
  2. Gao F, Miller JP, Miglior S, Beiser JA, Torri V, Kass MA, Gordon MO. "A Joint Model for Prognostic Effect of Biomarker Variability on Outcomes: long-term intraocular pressure (IOP) fluctuation on the risk of developing primary open-angle glaucoma (POAG)." JP J Biostat. 2011 May 1;5(2):73-96.
  3. Bhorade AM, Wilson BS, Gordon MO, Palmberg P, Weinreb RN, Miller E, Chang RT, Kass MA; Ocular Hypertension Treatment Study Group. "The utility of the monocular trial: data from the ocular hypertension treatment study." Ophthalmology. 2010 Nov;117(11):2047-54.
  4. Kymes SM, Plotzke MR, Kass MA, Boland MV, Gordon MO. "Effect of patient's life expectancy on the cost-effectiveness of treatment for ocular hypertension." Arch Ophthalmol. 2010 May;128(5):613-8.
  5. Kass MA, Gordon MO, Gao F, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JK, Miller JP, Parrish RK, Wilson MR; Ocular Hypertension Treatment Study Group. "Delaying treatment of ocular hypertension: the ocular hypertension treatment study." Arch Ophthalmol. 2010 Mar;128(3):276-87.
  6. Barnett EM, Fantin A, Wilson BS, Kass MA, Gordon MO; Ocular Hypertension Treatment Study Group. "The incidence of retinal vein occlusion in the ocular hypertension treatment study." Ophthalmology. 2010 Mar;117(3):484-8.
  7. Bhorade AM, Gordon MO, Wilson B, Weinreb RN, Kass MA; Ocular Hypertension Treatment Study Group. "Variability of intraocular pressure measurements in observation participants in the ocular hypertension treatment study." Ophthalmology. 2009 Apr;116(4):717-24.
  8. Ocular Hypertension Treatment Study Group; European Glaucoma Prevention Study Group, Gordon MO, Torri V, Miglior S, Beiser JA, Floriani I, Miller JP, Gao F, Adamsons I, Poli D, D'Agostino RB, Kass MA. "Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension." Ophthalmology. 2007 Jan;114(1):10-9.
  9. Kymes SM, Kass MA, Anderson DR, Miller JP, Gordon MO; Ocular Hypertension Treatment Study Group (OHTS). "Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study." Am J Ophthalmol. 2006 Jun;141(6):997-1008.
  10. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Kass MA. "The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma." Arch Ophthalmol. 2002 Jun;120(6):714-20; discussion 829-30.

Internal Links

DOVS Portal

Follow Us: